Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 7;38(6):BSR20180961.
doi: 10.1042/BSR20180961. Print 2018 Dec 21.

Expression of human miR-200b-3p and -200c-3p in cytomegalovirus-infected tissues

Affiliations

Expression of human miR-200b-3p and -200c-3p in cytomegalovirus-infected tissues

Kyoung Hwa Lee et al. Biosci Rep. .

Abstract

Human cytomegalovirus (HCMV) infection can cause inflammatory tissue-invasive end-organ diseases upon lytic replication. In humans, mature miR-200b-3p and -200c-3p suppress the synthesis of HCMV immediate early 2 (IE2) protein by binding to the 3'-UTR of the mRNA encoded by the unique long (UL) 122-123 region in human foreskin fibroblasts and pre-transplant peripheral blood mononuclear cells stimulated with HCMV. The present study aimed to quantitate the expression of Homo sapiens (hsa)-miR-200b-3p and 200c-3p in HCMV-infected tissues. We collected 240 HCMV-infected and 154 HCMV-non-infected, formalin-fixed, paraffin-embedded tissue samples of the gastrointestinal (GI) tract and bronchi/lungs. MiRNAs, HCMV, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were quantitated by quantitative reverse transcription-PCR (qRT-PCR) and quantitative PCR (qPCR) on the basis of standard curves generated using miRNA mimics, the HCMV strain from National Institute for Biological Standards and Control (NIBSC) 09/162, and GAPDH control. To avoid the effect of cell counts on the qRT-PCR and qPCR results, the data were normalized to GAPDH levels. HCMV-infected tissues had significantly lower levels of 200b-3p/GAPDH (3.03 ± 1.50 compared with 3.98 ± 1.08 log10 copies/μl, P<0.001) and 200c-3p/GAPDH (4.67 ± 1.84 compared with 6.35 ± 1.47 log10 copies/μl, P<0.001) than normal tissues. The values for 200b-3p/GAPDH (r = -0.51, P<0.001) and 200c-3p/GAPDH (r = -0.54, P<0.001) were significantly inversely correlated with HCMV load. Low tissue levels of 200b-3p and 200c-3p in humans are associated with cytopathic inflammation due to HCMV infection.

Keywords: cytomegalovirus; immediate early protein 2; microRNA; tissues.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. Differences and correlation between levels of hsa-miR-200b-3p, -200c-3p, and -429 in 394 analyzed tissues samples
(A) Differences in hsa-miR-200b-3p, -200c-3p, and -429 levels after normalization to GAPDH. Bars represent means and S.D. Dotted line indicates limit of detection (100 copies/μl of input nucleic acid). *P-value between three miRs by ANOVA test, **P<0.001 between two miRs by Bonferroni’s multiple comparisons tests. (B) Correlation between 200b-3p and 200c-3p after normalization to GAPDH. The levels of hsa-miR-200b-3p/GAPDH and -200c-3p/GAPDH are strongly correlated, with r = 0.87 (95% CI, 0.86–0.87) and P<0.001. ‘Nucleic acid’ stands for DNA for GAPDH and RNA for miRNAs. Each dot corresponds to the miRNA/GAPDH level expressed as log10 copies/μl of input nucleic acid in all figures.
Figure 2
Figure 2. Difference of hsa-miR-200b-3p and -200c-3p levels between HCMV-infected (n=240) and non-infected (n=154) FFPE tissues
(A), (B) Bars indicate means and S.D. Dotted lines represent limit of detection (100 copies/μl of input nucleic acid). ‘Nucleic acid’ stands for DNA for GAPDH and RNA for miRNAs. Each dot corresponds to the miRNA/GAPDH level expressed log10 copies/μl of input nucleic acid in all figures.
Figure 3
Figure 3. Difference in hsa-miR-200b-3p and -200c-3p levels according to tissue type
(A) Upper-GI tract samples originating from esophagus and stomach, including 67 HCMV-infected and 56 non-infected FFPE tissues. The percentage of samples with undetectable level of hsa-miR- 200b-3p/GAPDH (21.7 compared with 0.0%) was significantly higher in HCMV-infected than non-infected upper-GI tract tissues (P<0.001). However, the percentage of undetectable 200c-3p/GAPDH (4.3 compared with 0.0%) was similar between the two groups (P=0.121). (B) Lower-GI tract samples from duodenum, cecum, terminal ileum, colon, and rectum, including 168 HCMV-infected and 79 normal FFPE tissues. The percentage of samples with undetectable level of hsa-miR-200b-3p/GAPDH (23.0 compared with 0.0%) was significantly higher in HCMV-infected than non-infected lower-GI-tract tissues (P<0.001). For 200c-3p, values normalized to GAPDH had a significantly high undetectable percentage (12.1 compared with 0.0%, P<0.001). (C) Lung samples, including 5 HCMV-infected and 19 normal FFPE tissues. In lung, the 200b-3p/GAPDH and 200c-3p/GAPDH levels did not show significant difference between two groups (P=0.297 and 0.120, respectively). *P<0.001. P-values for GI tract and lung samples were obtained through independent t test and Mann–Whitney U test, respectively. In (A,B), height of boxes and upper/lower lines indicate mean and S.D. In (C), bars represent median and 25 or 75 percentile values. Each dot corresponds to the miRNA/GAPDH levels expressed as log10 copies/μl of input nucleic acid in all figures.
Figure 4
Figure 4. Correlation between HCMV and hsa-miR-200b-3p or -200c-3p levels in HCMV-infected FFPE tissues
Straight and dotted lines represent each equation according to r coefficient and 95% CI values, respectively. Each dot corresponds to the miRNA/GAPDH or HCMV level expressed as log10 copies/μl of input nucleic acid or DNA in all figures. ‘Nucleic acid’ stands for DNA for GAPDH and RNA for miRNAs.

Similar articles

Cited by

References

    1. Razonable R.R. and Humar A. (2013) Cytomegalovirus in solid organ transplantation. Am. J. Transplant. 13, 93–106 10.1111/ajt.12103 - DOI - PubMed
    1. Kotton C.N. et al. (2013) Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 96, 333–360 10.1097/TP.0b013e31829df29d - DOI - PubMed
    1. Fuji S., Einsele H. and Kapp M. (2017) Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options. Curr. Opin. Infect. Dis. 30, 372–376 10.1097/QCO.0000000000000375 - DOI - PubMed
    1. Kalil A.C. and Florescu D.F. (2009) Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit. Care Med. 37, 2350–2358 10.1097/CCM.0b013e3181a3aa43 - DOI - PubMed
    1. Limaye A.P. et al. (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300, 413–422 10.1001/jama.2008.697 - DOI - PMC - PubMed

Publication types